Abstract:ABSTRACT Bacterial growth and metabolic rates are often closely related. However, under antibiotic selection, a paradox in this relationship arises: antibiotic efficacy decreases when bacteria are metabolically dormant, yet antibiotics select for resistant cells that grow fastest during treatment. That is, antibiotic selection counterintuitively favors bacteria with fast growth but slow metabolism. Despite this apparent contradiction, antibiotic resistant cells have historically been characterized primarily in the context of growth, whereas the extent of analogous changes in metabolism is comparatively unknown. Here, we observed that previously evolved antibiotic-resistant strains exhibited a unique relationship between growth and metabolism whereby nutrient utilization became more efficient, regardless of the growth rate. To better understand this unexpected phenomenon, we used a simplified model to simulate bacterial populations adapting to sub-inhibitory antibiotic selection through successive bottlenecking events. Simulations predicted that sub-inhibitory bactericidal antibiotic concentrations could select for enhanced metabolic efficiency, defined based on nutrient utilization: drug-adapted cells are able to achieve the same biomass while utilizing less substrate, even in the absence of treatment. Moreover, simulations predicted that restoring metabolic efficiency would re-sensitize resistant bacteria exhibiting metabolic-dependent resistance; we confirmed this result using adaptive laboratory evolutions of Escherichia coli under carbenicillin treatment. Overall, these results indicate that metabolic efficiency is under direct selective pressure during antibiotic treatment and that differences in evolutionary context may determine both the efficacy of different antibiotics and corresponding re-sensitization approaches. IMPORTANCE The sustained emergence of antibiotic-resistant pathogens combined with the stalled drug discovery pipelines highlights the critical need to better understand the underlying evolution mechanisms of antibiotic resistance. To this end, bacterial growth and metabolic rates are often closely related, and resistant cells have historically been characterized exclusively in the context of growth. However, under antibiotic selection, antibiotics counterintuitively favor cells with fast growth, and slow metabolism. Through an integrated approach of mathematical modeling and experiments, this study thereby addresses the significant knowledge gap of whether antibiotic selection drives changes in metabolism that complement, and/or act independently, of antibiotic resistance phenotypes.

Antibiotic Treatment Enhances the Genome-Wide Mutation Rate of Target Cells.

Contribution of the SOS Response and the DNA Repair Systems to Norfloxacin Induced Mutations in E. Coli

Copper-based fungicide copper hydroxide accelerates the evolution of antibiotic resistance via gene mutations in <i>Escherichia coli</i>

Oxidative DNA Damage is Important to the Evolution of Antibiotic Resistance: Evidence of Mutation Bias and Its Medicinal Implications

The Antibiotic Dosage of Fastest Resistance Evolution: Gene Amplifications Underpinning the Inverted-U

Conserved Evolutionary Trajectory Can Be Perturbed to Prevent Resistance Evolution under Norfloxacin Pressure by Forcing Mycobacterium smegmatis on Alternate Evolutionary Paths

Fast Evolution of SOS-Independent Multi-Drug Resistance in Bacteria

The Diverse Phenotypic and Mutational Landscape Induced by Fluoroquinolone Treatment

Genetic Adaptation to Amoxicillin in Escherichia coli: The Limited Role of dinB and katE

Common regulatory mutation increases single-cell survival to antibiotic exposures in .

Antibiotic resistant bacteria survive treatment by doubling while shrinking

Genomic evolution of bacterial populations under coselection by antibiotics and phage

ppGpp and RNA-polymerase backtracking guide antibiotic-induced mutable gambler cells

acquisition of antibiotic resistance in six species of bacteria

Sub-inhibitory antibiotic treatment selects for enhanced metabolic efficiency

Low-Level Cefepime Exposure Induces High-Level Resistance in Environmental Bacteria: Molecular Mechanism and Evolutionary Dynamics.

Antidepressants Can Induce Mutation and Enhance Persistence Toward Multiple Antibiotics

Integrating CRISPR-Enabled Trackable Genome Engineering and Transcriptomic Analysis of Global Regulators for Antibiotic Resistance Selection and Identification in Escherichia coli

Antibiotic dose and nutrient availability differentially drive the evolution of antibiotic resistance and persistence

In Vitro Microevolution and Co-Selection Assessment of Amoxicillin and Cefotaxime Impact on Escherichia coli Resistance Development

Adaptation to the cervical environment is associated with increased antibiotic susceptibility in Neisseria gonorrhoeae